tiprankstipranks
Advertisement
Advertisement
Immutep downgraded to Hold from Buy at Maxim
PremiumThe FlyImmutep downgraded to Hold from Buy at Maxim
16d ago
Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls
Premium
The Fly
Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls
16d ago
Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study
Premium
The Fly
Immutep says IDMC recommends discontinuation for TACTI-004 Phase III study
16d ago
Immutep Reaches 50% Enrolment in Global Phase III Lung Cancer Trial
PremiumCompany AnnouncementsImmutep Reaches 50% Enrolment in Global Phase III Lung Cancer Trial
2M ago
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
Premium
The Fly
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
2M ago
Immutep Secures Dr. Reddy’s Licensing Deal and Reports Strong Q2 FY26 Clinical and Cash Progress
Premium
Company Announcements
Immutep Secures Dr. Reddy’s Licensing Deal and Reports Strong Q2 FY26 Clinical and Cash Progress
2M ago
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
PremiumThe FlyImmutep announces progress in global TACTI-004 Phase III, enrollment continues
3M ago
Immutep’s Strategic Partnership with Dr. Reddy’s Fuels Growth Potential and Strengthens Financial Position
Premium
Ratings
Immutep’s Strategic Partnership with Dr. Reddy’s Fuels Growth Potential and Strengthens Financial Position
4M ago
Immutep and Dr. Reddy’s Forge Strategic Collaboration for Eftilagimod Alfa
Premium
Company Announcements
Immutep and Dr. Reddy’s Forge Strategic Collaboration for Eftilagimod Alfa
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100